[1]
Ashcheulova, T.V., Kompaniiets, K.M., Herasymchuk, N.M. and Sytina, I.V. 2023. Pathogenetic justification of sacubitril / valsartan use in respiratory-cardial comorbidity. Pathologia. 19, 3 (Jan. 2023), 236–246. DOI:https://doi.org/10.14739/2310-1237.2022.3.266425.